DDX3X_MOUSE - dbPTM
DDX3X_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID DDX3X_MOUSE
UniProt AC Q62167
Protein Name ATP-dependent RNA helicase DDX3X
Gene Name Ddx3x
Organism Mus musculus (Mouse).
Sequence Length 662
Subcellular Localization Nucleus speckle. Cytoplasm. Mitochondrion outer membrane. Located predominantly in nuclear speckles and, at low levels, throughout the cytoplasm. Located to the outer side of nuclear pore complexes (NPC). Shuttles between the nucleus and the cytoplas
Protein Description Multifunctional ATP-dependent RNA helicase. The ATPase activity can be stimulated by various ribo- and deoxynucleic acids indicative for a relaxed substrate specificity. In vitro can unwind partially double-stranded DNA with a preference for 5'-single-stranded DNA overhangs. Is involved in several steps of gene expression, such as transcription, mRNA maturation, mRNA export and translation. However, the exact mechanisms are not known and some functions may be specific for a subset of mRNAs. Involved in transcriptional regulation. Can enhance transcription from the CDKN1A/WAF1 promoter in a SP1-dependent manner. Found associated with the E-cadherin promoter and can down-regulate transcription from the promoter. Involved in regulation of translation initiation. Proposed to be involved in positive regulation of translation such as of cyclin E1/CCNE1 mRNA and specifically of mRNAs containing complex secondary structures in their 5'UTRs; these functions seem to require RNA helicase activity. Specifically promotes translation of a subset of viral and cellular mRNAs carrying a 5'proximal stem-loop structure in their 5'UTRs and cooperates with the eIF4F complex. Proposed to act prior to 43S ribosomal scanning and to locally destabilize these RNA structures to allow recognition of the mRNA cap or loading onto the 40S subunit. After association with 40S ribosomal subunits seems to be involved in the functional assembly of 80S ribosomes; the function seems to cover translation of mRNAs with structured and non-structured 5'UTRs and is independent of RNA helicase activity. Also proposed to inhibit cap-dependent translation by competetive interaction with EIF4E which can block the EIF4E:EIF4G complex formation. Proposed to be involved in stress response and stress granule assembly; the function is independent of RNA helicase activity and seems to involve association with EIF4E. May be involved in nuclear export of specific mRNAs but not in bulk mRNA export via interactions with XPO1 and NXF1. Also associates with polyadenylated mRNAs independently of NXF1. Associates with spliced mRNAs in an exon junction complex (EJC)-dependent manner and seems not to be directly involved in splicing. May be involved in nuclear mRNA export by association with DDX5 and regulating its nuclear location. Involved in innate immune signaling promoting the production of type I interferon (IFN-alpha and IFN-beta); proposed to act as viral RNA sensor, signaling intermediate and transcriptional coactivator. Involved in TBK1 and IKBKE-dependent IRF3 activation leading to IFNB induction, plays a role of scaffolding adapter that links IKBKE and IRF3 and coordinates their activation. Also found associated with IFNB promoters; the function is independent of IRF3. Can bind to viral RNAs and via association with MAVS/IPS1 and DDX58/RIG-I is thought to induce signaling in early stages of infection. Involved in regulation of apoptosis. May be required for activation of the intrinsic but inhibit activation of the extrinsic apoptotic pathway. Acts as an antiapoptotic protein through association with GSK3A/B and BIRC2 in an apoptosis antagonizing signaling complex; activation of death receptors promotes caspase-dependent cleavage of BIRC2 and DDX3X and relieves the inhibition. May be involved in mitotic chromosome segregation. Is an allosteric activator of CSNK1E, it stimulates CSNK1E-mediated phosphorylation of DVL2 and is involved in the positive regulation of canonical Wnt signaling (By similarity)..
Protein Sequence MSHVAVENALGLDQQFAGLDLNSSDNQSGGSTASKGRYIPPHLRNREATKGFYDKDSSGWSSSKDKDAYSSFGSRGDSRGKSSFFGDRGSGSRGRFDDRGRGDYDGIGGRGDRSGFGKFERGGNSRWCDKSDEDDWSKPLPPSERLEQELFSGGNTGINFEKYDDIPVEATGNNCPPHIESFSDVEMGEIIMGNIELTRYTRPTPVQKHAIPIIKEKRDLMACAQTGSGKTAAFLLPILSQIYADGPGEALRAMKENGRYGRRKQYPISLVLAPTRELAVQIYEEARKFSYRSRVRPCVVYGGAEIGQQIRDLERGCHLLVATPGRLVDMMERGKIGLDFCKYLVLDEADRMLDMGFEPQIRRIVEQDTMPPKGVRHTMMFSATFPKEIQMLARDFLDEYIFLAVGRVGSTSENITQKVVWVEEIDKRSFLLDLLNATGKDSLTLVFVETKKGADSLEDFLYHEGYACTSIHGDRSQRDREEALHQFRSGKSPILVATAVAARGLDISNVKHVINFDLPSDIEEYVHRIGRTGRVGNLGLATSFFNERNINITKDLLDLLVEAKQEVPSWLENMAFEHHYKGSSRGRSKSSRFSGGFGARDYRQSSGASSSSFSSSRASSSRSGGGGHGGSRGFGGGGYGGFYNSDGYGGNYNSQGVDWWGN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSHVAVENA
------CCCHHHHCC
27.0310859333
2Phosphorylation------MSHVAVENA
------CCCHHHHCC
27.0329514104
23PhosphorylationFAGLDLNSSDNQSGG
HCCCCCCCCCCCCCC
46.4926824392
24PhosphorylationAGLDLNSSDNQSGGS
CCCCCCCCCCCCCCC
39.2426643407
28PhosphorylationLNSSDNQSGGSTASK
CCCCCCCCCCCCCCC
51.9126643407
31PhosphorylationSDNQSGGSTASKGRY
CCCCCCCCCCCCCCC
25.0726643407
32PhosphorylationDNQSGGSTASKGRYI
CCCCCCCCCCCCCCC
37.9226643407
34PhosphorylationQSGGSTASKGRYIPP
CCCCCCCCCCCCCCH
35.4126643407
50AcetylationLRNREATKGFYDKDS
HCCCHHHCCCCCCCC
54.8122902405
53PhosphorylationREATKGFYDKDSSGW
CHHHCCCCCCCCCCC
30.6522817900
55AcetylationATKGFYDKDSSGWSS
HHCCCCCCCCCCCCC
48.4023806337
57PhosphorylationKGFYDKDSSGWSSSK
CCCCCCCCCCCCCCC
36.1729899451
61PhosphorylationDKDSSGWSSSKDKDA
CCCCCCCCCCCCHHH
28.4126745281
62PhosphorylationKDSSGWSSSKDKDAY
CCCCCCCCCCCHHHH
34.5926745281
63PhosphorylationDSSGWSSSKDKDAYS
CCCCCCCCCCHHHHH
39.0829899451
66MalonylationGWSSSKDKDAYSSFG
CCCCCCCHHHHHHCC
48.2526320211
69PhosphorylationSSKDKDAYSSFGSRG
CCCCHHHHHHCCCCC
18.2520116462
70PhosphorylationSKDKDAYSSFGSRGD
CCCHHHHHHCCCCCC
22.4025159016
71PhosphorylationKDKDAYSSFGSRGDS
CCHHHHHHCCCCCCC
22.4326824392
74PhosphorylationDAYSSFGSRGDSRGK
HHHHHCCCCCCCCCC
30.9523684622
78PhosphorylationSFGSRGDSRGKSSFF
HCCCCCCCCCCCCCC
45.8425266776
81UbiquitinationSRGDSRGKSSFFGDR
CCCCCCCCCCCCCCC
41.64-
82PhosphorylationRGDSRGKSSFFGDRG
CCCCCCCCCCCCCCC
34.8927087446
83PhosphorylationGDSRGKSSFFGDRGS
CCCCCCCCCCCCCCC
28.2526824392
88MethylationKSSFFGDRGSGSRGR
CCCCCCCCCCCCCCC
41.37-
90PhosphorylationSFFGDRGSGSRGRFD
CCCCCCCCCCCCCCC
34.1927087446
92PhosphorylationFGDRGSGSRGRFDDR
CCCCCCCCCCCCCCC
33.0027087446
93DimethylationGDRGSGSRGRFDDRG
CCCCCCCCCCCCCCC
43.78-
93MethylationGDRGSGSRGRFDDRG
CCCCCCCCCCCCCCC
43.78-
95MethylationRGSGSRGRFDDRGRG
CCCCCCCCCCCCCCC
30.61-
101MethylationGRFDDRGRGDYDGIG
CCCCCCCCCCCCCCC
35.3924129315
104PhosphorylationDDRGRGDYDGIGGRG
CCCCCCCCCCCCCCC
20.9216873679
110MethylationDYDGIGGRGDRSGFG
CCCCCCCCCCCCCCC
38.3324129315
113MethylationGIGGRGDRSGFGKFE
CCCCCCCCCCCCCCC
41.31-
114PhosphorylationIGGRGDRSGFGKFER
CCCCCCCCCCCCCCC
43.12-
118UbiquitinationGDRSGFGKFERGGNS
CCCCCCCCCCCCCCC
41.62-
118AcetylationGDRSGFGKFERGGNS
CCCCCCCCCCCCCCC
41.62-
128GlutathionylationRGGNSRWCDKSDEDD
CCCCCCCCCCCCCCC
4.6024333276
130AcetylationGNSRWCDKSDEDDWS
CCCCCCCCCCCCCCC
57.5823806337
131PhosphorylationNSRWCDKSDEDDWSK
CCCCCCCCCCCCCCC
32.7426643407
152PhosphorylationRLEQELFSGGNTGIN
HHHHHHHCCCCCCCC
59.4229514104
183PhosphorylationPPHIESFSDVEMGEI
CCCCCCCCCCCCCEE
50.45-
200PhosphorylationGNIELTRYTRPTPVQ
EEEEEEEECCCCCCH
11.2329514104
215UbiquitinationKHAIPIIKEKRDLMA
HCCCHHHHCHHCHHH
58.88-
223S-nitrosocysteineEKRDLMACAQTGSGK
CHHCHHHHHHCCCCH
1.47-
223S-nitrosylationEKRDLMACAQTGSGK
CHHCHHHHHHCCCCH
1.4720925432
223S-palmitoylationEKRDLMACAQTGSGK
CHHCHHHHHHCCCCH
1.4728526873
226PhosphorylationDLMACAQTGSGKTAA
CHHHHHHCCCCHHHH
18.1324759943
228PhosphorylationMACAQTGSGKTAAFL
HHHHHCCCCHHHHHH
40.2724759943
240PhosphorylationAFLLPILSQIYADGP
HHHHHHHHHHHCCCC
18.4328059163
243PhosphorylationLPILSQIYADGPGEA
HHHHHHHHCCCCHHH
7.3322817900
264UbiquitinationNGRYGRRKQYPISLV
HCCCCCCCCCCCEEE
53.47-
266PhosphorylationRYGRRKQYPISLVLA
CCCCCCCCCCEEEEC
12.9329514104
283PhosphorylationRELAVQIYEEARKFS
HHHHHHHHHHHHHCC
7.2222817900
293PhosphorylationARKFSYRSRVRPCVV
HHHCCHHHCCCCEEE
27.22-
298S-nitrosocysteineYRSRVRPCVVYGGAE
HHHCCCCEEEECCHH
1.96-
298S-palmitoylationYRSRVRPCVVYGGAE
HHHCCCCEEEECCHH
1.9628526873
298S-nitrosylationYRSRVRPCVVYGGAE
HHHCCCCEEEECCHH
1.9620925432
301PhosphorylationRVRPCVVYGGAEIGQ
CCCCEEEECCHHHHH
6.8822817900
317S-nitrosocysteineIRDLERGCHLLVATP
HHHHHCCCEEEEECC
2.27-
317S-palmitoylationIRDLERGCHLLVATP
HHHHHCCCEEEEECC
2.2728526873
317S-nitrosylationIRDLERGCHLLVATP
HHHHHCCCEEEEECC
2.2720925432
323PhosphorylationGCHLLVATPGRLVDM
CCEEEEECCCHHHHH
20.8526824392
335UbiquitinationVDMMERGKIGLDFCK
HHHHHCCCCCHHHHH
39.56-
335MalonylationVDMMERGKIGLDFCK
HHHHHCCCCCHHHHH
39.5626320211
410PhosphorylationLAVGRVGSTSENITQ
HHCCCCCCCCCCCCE
26.3830635358
411PhosphorylationAVGRVGSTSENITQK
HCCCCCCCCCCCCEE
33.8526745281
412PhosphorylationVGRVGSTSENITQKV
CCCCCCCCCCCCEEE
30.2829176673
456PhosphorylationETKKGADSLEDFLYH
EECCCCCCHHHHHHC
32.8822817900
462PhosphorylationDSLEDFLYHEGYACT
CCHHHHHHCCCCCCC
9.6022817900
466PhosphorylationDFLYHEGYACTSIHG
HHHHCCCCCCCCCCC
8.7718034455
468S-nitrosocysteineLYHEGYACTSIHGDR
HHCCCCCCCCCCCCC
2.00-
468S-nitrosylationLYHEGYACTSIHGDR
HHCCCCCCCCCCCCC
2.0020925432
508PhosphorylationAARGLDISNVKHVIN
HHCCCCCCCCEEEEE
34.9322006019
511UbiquitinationGLDISNVKHVINFDL
CCCCCCCEEEEECCC
36.08-
520PhosphorylationVINFDLPSDIEEYVH
EEECCCCCCHHHHHH
59.5226745281
525PhosphorylationLPSDIEEYVHRIGRT
CCCCHHHHHHHHCCC
6.7026745281
554UbiquitinationERNINITKDLLDLLV
CCCCCCCHHHHHHHH
42.45-
580PhosphorylationNMAFEHHYKGSSRGR
HHHHHHCCCCCCCCC
20.9629514104
583PhosphorylationFEHHYKGSSRGRSKS
HHHCCCCCCCCCCCC
16.8327600695
588PhosphorylationKGSSRGRSKSSRFSG
CCCCCCCCCCCCCCC
39.4529514104
590PhosphorylationSSRGRSKSSRFSGGF
CCCCCCCCCCCCCCC
28.1727087446
591PhosphorylationSRGRSKSSRFSGGFG
CCCCCCCCCCCCCCC
40.8727600695
592DimethylationRGRSKSSRFSGGFGA
CCCCCCCCCCCCCCC
36.52-
592MethylationRGRSKSSRFSGGFGA
CCCCCCCCCCCCCCC
36.52-
594PhosphorylationRSKSSRFSGGFGARD
CCCCCCCCCCCCCCC
36.5827087446
602PhosphorylationGGFGARDYRQSSGAS
CCCCCCCHHCCCCCC
12.6629899451
605PhosphorylationGARDYRQSSGASSSS
CCCCHHCCCCCCCCC
23.0325521595
606PhosphorylationARDYRQSSGASSSSF
CCCHHCCCCCCCCCC
30.0025521595
609PhosphorylationYRQSSGASSSSFSSS
HHCCCCCCCCCCCCC
33.9925521595
610PhosphorylationRQSSGASSSSFSSSR
HCCCCCCCCCCCCCC
29.4830635358
611PhosphorylationQSSGASSSSFSSSRA
CCCCCCCCCCCCCCC
32.6730635358
612PhosphorylationSSGASSSSFSSSRAS
CCCCCCCCCCCCCCC
30.9725521595
614PhosphorylationGASSSSFSSSRASSS
CCCCCCCCCCCCCCC
29.3829472430
615PhosphorylationASSSSFSSSRASSSR
CCCCCCCCCCCCCCC
23.1023984901
616PhosphorylationSSSSFSSSRASSSRS
CCCCCCCCCCCCCCC
30.5723984901
617MethylationSSSFSSSRASSSRSG
CCCCCCCCCCCCCCC
40.20-
619PhosphorylationSFSSSRASSSRSGGG
CCCCCCCCCCCCCCC
27.9527149854
621PhosphorylationSSSRASSSRSGGGGH
CCCCCCCCCCCCCCC
28.1529899451
632MethylationGGGHGGSRGFGGGGY
CCCCCCCCCCCCCCC
47.9724129315

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of DDX3X_MOUSE !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of DDX3X_MOUSE !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of DDX3X_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of DDX3X_MOUSE !!

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of DDX3X_MOUSE

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"An N-acetylated natural ligand of human histocompatibility leukocyteantigen (HLA)-B39. Classical major histocompatibility complex class Iproteins bind peptides with a blocked NH(2) terminus in vivo.";
Yaguee J., Alvarez I., Rognan D., Ramos M., Vazquez J.,Lopez de Castro J.A.;
J. Exp. Med. 191:2083-2092(2000).
Cited for: PROTEIN SEQUENCE OF 2-10, AND ACETYLATION AT SER-2.
Phosphorylation
ReferencePubMed
"The phagosomal proteome in interferon-gamma-activated macrophages.";
Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.;
Immunity 30:143-154(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-594, AND MASSSPECTROMETRY.
"Identification of phosphoproteins and their phosphorylation sites inthe WEHI-231 B lymphoma cell line.";
Shu H., Chen S., Bi Q., Mumby M., Brekken D.L.;
Mol. Cell. Proteomics 3:279-286(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74, AND MASSSPECTROMETRY.

TOP